Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Patents
-
India joins hands with UK, US to protect traditional knowledge
India is expecting a rapid decline in the number of patents claim over its traditional medicinal formulations at the US and UK patents office following TKDL (Traditional Knowledge Digital Library) Access Agreements with these two countries.
-
Pharma firms join hands to oppose 90 patent claims
A GROUP of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications sought by global drugmakers and some local companies, terming them as frivolous patent claims.
-
Glenmark settles malaria drug patent row with GSK
GLENMARK Pharmaceuticals said on Monday its unit entered an outof-court settlement with Glaxo-SmithKline LLC over patent actions on doses of atovaquone and proguanil hydrochloride, the generic version of GSK
-
Cipla unveils version of Bayers cancer drug at one-tenth price
CIPLA has launched a copycat version of German pharma company Bayer AG
-
It has been the prime beneficiary of food crisis
K P Prabhakaran Nair Monsanto devotes an annual budget of $10 million to harassing, intimidating, suing -and in some cases bankrupting -American farmers over alleged improper use of its patented seeds. This will become the norm for India as well
-
Vested interests behind discussion on patents
Civil Society Groups Urge End To India Project, Allege Nexus With MNC Pharma Companies
-
Bayer files patent case against Cipla
GERMAN drugmaker Bayer has filed a patent infringement case against Cipla, the largest domestic drugseller, to stop the Mumbaibased company from selling its generic version of Bayer
-
Delhi HC rejects BMS plea to ban Ranbaxy generic
THE Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India